Radiation-induced lung fibrosis in a tumor-bearing mouse model is associated with enhanced Type-2 immunity

Journal of Radiation Research

Volumn 57, Issue 2, 2016, Pages 133-141

  Chen, Jing ^a   Wang, Yacheng ^a   Mei, Zijie ^a   Zhang, Shimin ^a   Yang, Jie ^a   Li, Xin ^a   Yao, Ye ^a   Xie, Conghua ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

fibrosis; immune imbalance; radiation induced lung injury; tumor bearing; Type 1 Type 2

Indexed keywords

BIOLOGICAL ORGANS; BODY FLUIDS; HISTOLOGY; HYDROXYPROLINE; IRRADIATION; MAMMALS; ONCOLOGY; RADIATION DAMAGE; RADIOTHERAPY;

FIBROSE; GUANINE; IMMUNE IMBALANCE; LUNG FIBROSIS; LUNG INJURY; PHOSPHOROTHIOATES; RADIATION-INDUCED; RADIATION-INDUCED LUNG INJURY; TUMOR-BEARING; TYPE-1/TYPE-2;

TUMORS;

CPG-OLIGONUCLEOTIDE; CYTOKINE; GATA3 PROTEIN, MOUSE; MESSENGER RNA; OLIGODEOXYRIBONUCLEOTIDE; STAT PROTEIN; T BOX TRANSCRIPTION FACTOR; T-BOX TRANSCRIPTION FACTOR TBX21; TRANSCRIPTION FACTOR GATA 3;

ANIMAL; BLOOD; C57BL MOUSE; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; FEMALE; GENETICS; IMMUNITY; IMMUNOLOGY; LUNG NEOPLASMS; METABOLISM; PHENOTYPE; PHOSPHORYLATION; PULMONARY FIBROSIS; RADIATION INJURY; REMISSION; X RAY;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GATA3 TRANSCRIPTION FACTOR; IMMUNITY; LUNG NEOPLASMS; MICE, INBRED C57BL; OLIGODEOXYRIBONUCLEOTIDES; PHENOTYPE; PHOSPHORYLATION; PULMONARY FIBROSIS; RADIATION INJURIES; REMISSION INDUCTION; RNA, MESSENGER; STAT TRANSCRIPTION FACTORS; T-BOX DOMAIN PROTEINS; X-RAYS;

EID: 84965165006     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1093/jrr/rrv077     Document Type: Article

References (34)

1. Roach M III, Gandara DR, Yuo H-S, et al. Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors. J Clin Oncol 1995;13:2606-12.
2. Shi A, Zhu G, Wu H, et al. Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy. Radiat Oncol 2010;5:35.
3. Kimura T, Togami T, Takashima H, et al. Radiation pneumonitis in patients with lung and mediastinal tumours: A retrospective study of risk factors focused on pulmonary emphysema. Br J Radiol 2012;85:135-41.
4. Yuan X, Liao Z, Liu Z, et al. Single nucleotide polymorphism at rs1982073:T869C of the TGFβ1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy. J Clin Oncol 2009;27: 3370-8.
5. Marks LB, Yu X, Vujaskovic Z, et al. Radiation-induced lung injury. Semin Radiat Oncol 2003;13:333-45.
6. Rubin P, Johnston CJ, Williams JP, et al. A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys 1995;33:99-109.
7. Schaue D, McBride WH. Links between innate immunity and normal tissue radiobiology. Radiat Res 2010;173: 406-17.
8. Rodemann HP, Bamberg M. Cellular basis of radiation-induced fibrosis. Radiother Oncol 1995;35:83-90.
9. Burnette B, Weichselbaum RR. Radiation as an immune modulator. Semin Radiat Oncol 2013;23:273-80.
10. Liang H, Deng L, Chmura S, et al. Radiation-induced equilibrium is a balance between tumor cell proliferation and T cell-mediated killing. J Immunol 2013;190:5874-81.
11. Finotto S, Neurath MF, Glickman JN, et al. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 2002;295:336-8.
12. Mowen KA, Glimcher LH. Signaling pathways in Th2 development. Immunol Rev 2004;202:203-22.
13. Wynn TA. Fibrotic disease and the TH1/TH2 paradigm. Nat Rev Immunol 2004;4:583-94.
14. Han G, Zhang H, Xie C-H, et al. Th2-like immune response in radiation-induced lung fibrosis. Oncol Rep 2011;26:383-8.
15. Masui Y, Asano Y, Shibata S, et al. A possible contribution of visfatin to the resolution of skin sclerosis in patients with diffuse cutaneous systemic sclerosis via a direct anti-fibrotic effect on dermal fibroblasts and Th1 polarization of the immune response. Rheumatology 2013;52:1239-44.
16. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010;140:883-99.
17. Neurath MF, Finotto S. The emerging role of T cell cytokines in non-small cell lung cancer. Cytokine Growth Factor Rev 2012;23:315-22.
18. Ortegel JW, Staren ED, Faber LP, et al. Modulation of tumorinfiltrating lymphocyte cytolytic activity against human non-small cell lung cancer. Lung Cancer 2002;36:17-25.
19. Huang M, Wang J, Lee P, et al. Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Res 1995;55:3847-53.
20. Shurin MR, Lu L, Kalinski P, et al. Th1/Th2 balance in cancer, transplantation and pregnancy. Springer Semin Immunopathol 1999;21:339-59.
21. Patel S, Vetale S, Teli P, et al. IL-10 production in non-small cell lung carcinoma patients is regulated by ERK, P38 and COX-2. J Cell Mol Med 2012;16:531-44.
22. Lazarevic V, Chen X, Shim JH, et al. Transcription factor T-bet represses TH17 differentiation by preventing Runx1-mediated activation of the gene encoding RORγt. Nat Immunol 2011;12: 96-104.
23. Karpathiou G, Giatromanolaki A, Koukourakis MI, et al. Histological changes after radiation therapy in patients with lung cancer: A prospective study. Anticancer Res 2014;34:3119-24.
24. Hübner RH, GitterW, ElMokhtari NE, et al. Standardized quantification of pulmonary fibrosis in histological samples. BioTechniques 2008;44:507-11. :14-7.
25. Sharma S, Stolina M, Lin Y, et al. T cell-derived IL-10 promotes lung cancer growth by suppressing both T cell and APC function. J Immunol 1999;163:5020-8.
26. Takeshima T, Chamoto K, Wakita D, et al. Local radiation therapy inhibits tumor growth through the generation of tumor-specific CTL: its potentiation by combination with Th1 cell therapy. Cancer Res 2010;70:2697-706.
27. Zhang H, Maric I, DiPrima MJ, et al. Fibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer. Blood 2013;122:1105-13.
28. Zhang H, Han G, Liu H, et al. The development of classically and alternatively activated macrophages has different effects on the varied stages of radiation-induced pulmonary injury in mice. J Radiat Res 2011;52:717-26.
29. Zhou Y-C, Liu J-Y, Li J, et al. Ionizing radiation promotes migration and invasion of cancer cells through transforming growth factor-beta-mediated epithelial-mesenchymal transition. Int J Radiat Oncol Biol Phys 2011;81:1530-7.
30. Anscher MS. Targeting the TGF-β1 pathway to prevent normal tissue injury after cancer therapy. Oncologist 2010;15:350-9.
31. Krieg AM. Toll-like receptor 9 (TLR9) agonists in the treatment of cancer. Oncogene 2008;27:161-7.
32. Chamoto K, Takeshima T, Wakita D, et al. Combination immunotherapy with radiation and CpG-based tumor vaccination for the eradication of radio-and immuno-resistant lung carcinoma cells. Cancer Sci 2009;100:934-9.
33. Pernis AB, Rothman PB. JAK-STAT signaling in asthma. J Clin Invest 2002;109:1279-83.
34. Suzuki Y, Wakita D, Chamoto K, et al. Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity. Cancer Res 2004;64:8754-60.